Skip to main content
logo
BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
4.550
-0.430 (-8.63%)
At close: Aug 28, 2026

BHIC Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.495.691.840.60.07-
Revenue Growth
7.77%208.34%208.73%761.80%--
Gross Profit
2.423.241.310.480.06-
Operating Income
-0.610.720.09-0.25-0.11-0.01
Net Income
-0.660.640.09-0.25-0.17-0.01
Earnings Per Share
-0.060.060.01-0.04-0.08-0.01
EPS Growth
-604.78%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.710.660.660.020.010
Total Debt
0.26--0.090.050
Net Cash (Debt)
0.450.660.66-0.07-0.03-0
Net Cash Growth
-63.89%-0.09%----
Net Cash Per Share
0.040.060.06-0.01-0.02-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.540.170.02-0.31-0.180
Free Cash Flow
-1.540.170.02-0.31-0.180
Free Cash Flow Growth
-642.53%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.77%56.97%70.94%81.06%86.01%-
Operating Margin
-13.65%12.64%4.72%-42.09%-161.99%-
Pretax Margin
-13.65%12.64%4.72%-42.09%-245.81%-
Profit Margin
-14.65%11.29%4.72%-42.09%-245.81%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-68.40483.87---
PS Ratio
11.917.7222.82615.03--